Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

J.C. Kluin-Nelemans, E. Hoster, J. Walewski, MD, S. Stilgenbauer, M.D., C. H. Geisler, C. Gisselbrecht, MD, U. Vehling-Kaiser, MD, J. K. Doorduijn, MD, M. Trneny, MD, B. Coiffier, MD, R. Forstpointner, MD, H. Tilly, MD, L. Kanz, MD, M. Szymczyk, MD, O. Hermine, MD, PhD, W. Klapper, MD, W. Hiddemann, MD, M. Unterhalt, PhD, M. H. Dreyling, MD

Blood (2011) 118 (21): 439.

https://doi.org/10.1182/blood.V118.21.439.439

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial.

Joachim Kienast, D.W. Beelen, H.J. Kolb, R. Schwerdtfeger, R. Arnold, A. Reichle, E. Holler, P. Staib, M.C. Sauerland, B. Berning, C. Schmid, M. Stelljes, W.E. Berdel, W. Hiddemann, T. Buchner

Blood (2007) 110 (11): 328.

https://doi.org/10.1182/blood.V110.11.328.328

Published: 2007

Journal Articles

Proteomic Pathway Discovery Reveals That C/EBPalpha Disperses PML Nuclear Bodies To Recruit Its Own Coactivators in a MAPK-Dependent Manner.

A. Meisel, R. Kachirin, M. Christopeit, W. Hiddemann, G. Behre

Blood (2004) 104 (11): 3557.

https://doi.org/10.1182/blood.V104.11.3557.3557

Published: 2004

Journal Articles

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller Hermelink, R. Herrman, J. Markova, A. Ho, W. Hiddemann, B. Doerken, R. Greil, B. Pfistner, for the German Hodgkin′s Lymphoma Study Group (GHSG), the Competence Network Malignant Lymphoma.

Blood (2004) 104 (11): 1308.

https://doi.org/10.1182/blood.V104.11.1308.1308

Published: 2004

Journal Articles

The Oncogenic Potential of the Homeobox Gene Cdx2 Is Depending on the MAPK Pathway and Can Be Antagonized by the MEK1/2 Inhibitor PD98059 in a Mouse Model of t(12;13)(p13;q12) Positive AML.

Vijay P.S. Rawat, Vegi M. Naidu, Christina Schessl, Monica Cusan, R.Keith Humphries, Ph.D, J. P. Lynch, Ph.D, W. Hiddemann, MD, Ph.D., Michaela Feuring-Buske, MD, Christian Buske, MD

Blood (2004) 104 (11): 1975.

https://doi.org/10.1182/blood.V104.11.1975.1975

Published: 2004

Journal Articles

Proteomic Analysis of Acute Promyelocytic Leukemia Reveals That PML-RARalpha Induces Cell Cycle Progression and Mitotic Exit by Increased Expression and Decreased Ser63 Phosphorylation of OP18.

A. PeerZada, M. Geletu, J. Pullikan, V. Reddy, W. Hiddemann, G. Behre

Blood (2004) 104 (11): 2028.

https://doi.org/10.1182/blood.V104.11.2028.2028

Published: 2004

Journal Articles

Proteomic Identification of the C/EBPalpha Multiprotein Complex Reveals That JNK1, an Activator of C/EBPalpha, Is Inactive in Acute Myeloid Leukemia.

A. Trivedi, D. Bararia, A. PeerZada, W. Hiddemann, G. Behre

Blood (2004) 104 (11): 2033.

https://doi.org/10.1182/blood.V104.11.2033.2033

Published: 2004

Journal Articles

Aerosolized Amphotericin B Inhalations as Prophylaxis of Invasive Aspergillus Infections During Prolonged Neutropenia: Results of a Prospective Randomized Multicenter Trial

S. Schwartz, G. Behre, V. Heinemann, H. Wandt, E. Schilling, M. Arning, A. Trittin, W.V. Kern, O. Boenisch, D. Bosse, K. Lenz, W.D. Ludwig, W. Hiddemann, W. Siegert, J. Beyer

Blood (1999) 93 (11): 3654–3661.

https://doi.org/10.1182/blood.V93.11.3654

Published: 1999

Journal Articles

MLL and CALM Are Fused to AF10 in Morphologically Distinct Subsets of Acute Leukemia With Translocation t(10;11): Both Rearrangements Are Associated With a Poor Prognosis

M.H. Dreyling, K. Schrader, C. Fonatsch, B. Schlegelberger, D. Haase, C. Schoch, W.-D. Ludwig, H. Löffler, T. Büchner, B. Wörmann, W. Hiddemann, S.K. Bohlander

Blood (1998) 91 (12): 4662–4667.

https://doi.org/10.1182/blood.V91.12.4662

Published: 1998

Journal Articles

Detection of Trisomy 12 and Rb-Deletion in CD34 + Cells of Patients With B-Cell Chronic Lymphocytic Leukemia

B. Gahn, C. Schäfer, J. Neef, C. Troff, M. Feuring-Buske, W. Hiddemann, B. Wörmann

Blood (1997) 89 (12): 4275–4281.

https://doi.org/10.1182/blood.V89.12.4275

Published: 1997

Journal Articles

Lymphoma classification--the gap between biology and clinical management is closing

W Hiddemann, DL Longo, B Coiffier, RI Fisher, F Cabanillas, F Cavalli, LM Nadler, VT De Vita, TA Lister, JO Armitage

Blood (1996) 88 (11): 4085–4089.

https://doi.org/10.1182/blood.V88.11.4085.4085

Published: 1996

Journal Articles

Improved outcome in adult B-cell acute lymphoblastic leukemia

Blood (1996) 87 (2): 495–508.

https://doi.org/10.1182/blood.V87.2.495.bloodjournal872495

Published: 1996

Journal Articles

Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis

M Kneba, I Bolz, B Linke, W Hiddemann

Blood (1995) 86 (10): 3930–3937.

https://doi.org/10.1182/blood.V86.10.3930.bloodjournal86103930

Published: 1995

Journal Articles

Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations

D Haase, M Feuring-Buske, S Konemann, C Fonatsch, C Troff, W Verbeek, A Pekrun, W Hiddemann, B Wormann

Blood (1995) 86 (8): 2906–2912.

https://doi.org/10.1182/blood.V86.8.2906.2906

Published: 1995

Journal Articles

Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

A Reiter, M Schrappe, WD Ludwig, W Hiddemann, S Sauter, G Henze, M Zimmermann, F Lampert, W Havers, D Niethammer

Blood (1994) 84 (9): 3122–3133.

https://doi.org/10.1182/blood.V84.9.3122.3122

Published: 1994

Journal Articles

Characterization of clone-specific rearrangement T-cell receptor gamma- chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing

M Kneba, I Bolz, B Linke, J Bertram, D Rothaupt, W Hiddemann

Blood (1994) 84 (2): 574–581.

https://doi.org/10.1182/blood.V84.2.574.574

Published: 1994

Journal Articles

Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse

T Buchner, W Hiddemann, M Koenigsmann, M Zuhlsdorf, B Wormann, A Boeckmann, EA Freire, G Innig, G Maschmeyer, WD Ludwig

Blood (1991) 78 (5): 1190–1197.

https://doi.org/10.1182/blood.V78.5.1190.1190

Published: 1991

Journal Articles

Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis

WD Ludwig, CR Bartram, J Ritter, A Raghavachar, W Hiddemann, G Heil, J Harbott, H Seibt-Jung, JV Teichmann, H Riehm

Blood (1988) 71 (6): 1518–1528.

https://doi.org/10.1182/blood.V71.6.1518.1518

Published: 1988

Journal Articles

High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia

W Hiddemann, H Kreutzmann, K Straif, WD Ludwig, R Mertelsmann, R Donhuijsen- Ant, E Lengfelder, Z Arlin, T Buchner

Blood (1987) 69 (3): 744–749.

https://doi.org/10.1182/blood.V69.3.744.744

Published: 1987

Journal Articles

Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia

W Hiddemann, BD Clarkson, T Buchner, MR Melamed, M Andreeff

Blood (1982) 59 (2): 216–225.

https://doi.org/10.1182/blood.V59.2.216.216

Published: 1982

NARROW

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial.

Proteomic Pathway Discovery Reveals That C/EBPalpha Disperses PML Nuclear Bodies To Recruit Its Own Coactivators in a MAPK-Dependent Manner.

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

The Oncogenic Potential of the Homeobox Gene Cdx2 Is Depending on the MAPK Pathway and Can Be Antagonized by the MEK1/2 Inhibitor PD98059 in a Mouse Model of t(12;13)(p13;q12) Positive AML.

Proteomic Analysis of Acute Promyelocytic Leukemia Reveals That PML-RARalpha Induces Cell Cycle Progression and Mitotic Exit by Increased Expression and Decreased Ser63 Phosphorylation of OP18.

Proteomic Identification of the C/EBPalpha Multiprotein Complex Reveals That JNK1, an Activator of C/EBPalpha, Is Inactive in Acute Myeloid Leukemia.

Aerosolized Amphotericin B Inhalations as Prophylaxis of Invasive Aspergillus Infections During Prolonged Neutropenia: Results of a Prospective Randomized Multicenter Trial

MLL and CALM Are Fused to AF10 in Morphologically Distinct Subsets of Acute Leukemia With Translocation t(10;11): Both Rearrangements Are Associated With a Poor Prognosis

Detection of Trisomy 12 and Rb-Deletion in CD34 + Cells of Patients With B-Cell Chronic Lymphocytic Leukemia

Lymphoma classification--the gap between biology and clinical management is closing

Improved outcome in adult B-cell acute lymphoblastic leukemia

Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis

Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations

Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

Characterization of clone-specific rearrangement T-cell receptor gamma- chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing

Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse

Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis

High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia

Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only